Laura Mueller
Child & Adolescent Psychiatry · Louisville, KYNPI 1902955313
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 159 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 13.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $974 and has fallen 87.2% since, to $124 in 2025. Among child & adolescent psychiatry clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 159 payments — averaging $23.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$496
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$451
- Lundbeck LLC$301
- Alkermes, Inc.$274
- Takeda Pharmaceuticals U.S.A., Inc.$242
- AbbVie$222
- plus $2K from 19 others
What the payments were for
- Food & beverage$3,724100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 22 | $496 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $451 |
| Lundbeck LLC | 18 | $301 |
| Alkermes, Inc. | 10 | $274 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $242 |
| AbbVie | 7 | $222 |
| Tris Pharma Inc | 7 | $212 |
| Neos Therapeutics, LP | 6 | $207 |
| Ironshore Pharmaceuticals Inc. | 5 | $202 |
| Johnson & Johnson | 10 | $168 |
| Axsome Therapeutics, Inc. | 4 | $163 |
| Teva Pharmaceuticals USA, Inc. | 10 | $146 |
| Bausch Health US, LLC | 8 | $139 |
| Corium, LLC | 5 | $95 |
| Vanda Pharmaceuticals Inc. | 4 | $73 |
| Shire North American Group Inc | 4 | $57 |
| Neurocrine Biosciences, Inc. | 3 | $51 |
| Sunovion Pharmaceuticals Inc. | 2 | $43 |
| Alfasigma USA, Inc. | 2 | $36 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
| Almatica Pharma LLC | 1 | $30 |
| Adlon Therapeutics L.p. | 2 | $27 |
| Rhodes Pharmaceuticals L.p. | 1 | $24 |
| Aytu Biopharma, Inc. | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$404
- CAPLYTA$349
- Adzenys XR-ODT$144
- Cotempla XR-ODT$144
- Karbinal$144
- Quillichew ER$125
- Quillivant$125
- Dyanavel XR$125
- Jornay PM 20mg capsules (Bottle of 100)$122
- VRAYLAR$118
- REXULTI$112
How this compares
$3,724 in reported general payments places this provider in the 95th percentile of 43 child & adolescent psychiatry providers in Kentucky.
See all child & adolescent psychiatry providers in Kentucky →
Other child & adolescent psychiatry in Louisville
- John GallehrLouisville$1K
- John SullivanLouisville$1K
- Varanise BookerLouisville$889
- Mehreen MansoorLouisville$602
- Joshua LagrantLouisville$274
- Christopher PetersLouisville$246
- John McCurdyLouisville$209
- Elizabeth CaudillLouisville$63
- Pukur PatelLouisville$26
- Allison YoderLouisville$26
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.